Android app Apple app link

Protagonist Therapeutics, Inc. (PTGX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$91.14
Day's range
$97.54

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/12/2026 UBS Alice Nettleton $184.00 $143.73   28.02%
09/01/2026 BMO Capital Evan Seigerman $190.00 $147.75   28.6%
09/01/2026 Barclays Etzer Darout $180.00 $147.75   21.83%
08/10/2026 Truist Financial Srikripa Devarakonda $170.00 $148.45   14.51%
08/10/2026 Goldman Sachs Richard Law $186.00 $145.87   27.51%
04/14/2026 Truist Financial Srikripa Devarakonda $121.00 $103.21   17.24%
03/18/2026 Jefferies Roger Song $121.00 $97.78   23.75%
10/28/2025 Truist Financial Srikripa Devarakonda $88.00 $76.68   14.76%
12/05/2024 BMO Capital Etzer Darout $62.00 $41.68   48.75%
11/22/2024 Truist Financial Srikripa Devarakonda $60.00 $46.46   29.14%
09/12/2024 H.C. Wainwright Douglas Tsao $50.00 $45.08   10.91%
06/17/2024 H.C. Wainwright Douglas Tsao $38.00 $32.86   15.64%

Protagonist Therapeutics Inc FAQ's

Protagonist Therapeutics Inc has been rated by research analysts at UBS, BMO Capital, Barclays, H.C. Wainwright, Truist Financial, Wedbush in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.